We’ve been making it better since 1994

Founded by our current CEO, David Navazio, in the 1990’s, Gentell is now one of the largest vertically-integrated wound care companies in the world.

Our recent expansion into Europe, and the acquisitions of Derma Sciences in Canada and First Water in the UK, represent our ongoing commitment to delivering cost-effective and innovative wound care solutions to clinical customers and OEM partners around the world.

About Gentell Europe

Gentell Europe, based in the heart of London, was established in 2023. The business forms a key part of Gentell’s vision to revolutionise wound care globally by developing deep in-house expertise in everything from the provision of clinical wound care services to the design and manufacture of advanced wound care products.

Whether we’re partnering with NHS Trusts or collaborating with private enterprises, we put patients at the centre of everything we do

Our Clinical Wound Advisors provide specialist assessments and advice, standardising the approach to care in accordance with The National Wound Care Strategy Programme and improving patient outcomes overall.

Fastcare® is our secret weapon for wound care providers. It’s the first integrated wound care solution; an EHR which allows clinicians to make decisions based on real time data and records our excellent results in every setting.

In the coming years the range is set to expand in line with several key product launches, and new technologies brought into Gentell from recent acquisitions.

What drives us?

The advanced wound care market is broken. The cost of managing wounds is too high. Worse still, patients are suffering for years with wounds that could be healed or avoided with simple interventions.

We’re on a mission to make patient care better through the delivery of affordable, efficient, patient-centric wound care.